Mark Levin

Mark Jay Levin founded Mayfield Fund LLC in 1987, where he worked as Partner from 1987 to 1993 and Third Rock Ventures LLC in 2007, where he is working as Founding Partner from 2007.
Mr. Levin also founded The Possible Project, Inc., where he is working as Executive Director.
Mr. Levin also currently works at NinePoint Medical, Inc., as Director, Corvia Medical, Inc., as Director, National Academy of Engineering, as Member, Partners In Health, as Trustee-Emeritus, TRV GP LLC, as Managing Member, and Personalized Medicine Coalition, as Member.
Mr. Levin also formerly worked at Cell Genesys, Inc., as Chief Executive Officer, StemCells, Inc., as Chief Executive Officer in 1992, Millennium Pharmaceuticals, Inc., as Chairman & Chief Executive Officer from 1996 to 2005, Focal, Inc., as Chief Executive Officer, Abgenix, Inc., as Chief Executive Officer from 1996 to 2000, Tularik, Inc., as Chief Executive Officer, CytoTherapuetics, Inc., as Chief Executive Officer from 1990 to 1992, Constellation Pharmaceuticals, Inc., as Chairman from 2010 to 2012, Blueprint Medicines Corp., as Chairman from 2011 to 2013, Sesen Bio, Inc., as Director from 2011 to 2014, Foundation Medicine, Inc., as Independent Director from 2013 to 2014, Warp Drive Bio, Inc., as Director, Voyager Therapeutics, Inc., as Independent Director from 2019 to 2022, Fulcrum Therapeutics, Inc., as Independent Director in 2022, Genentech, Inc., as Process Engineer & Project Leader, and Eli Lilly & Co., as Process Engineer & Project Leader.
Mr. Levin received his undergraduate degree in 1972 and graduate degree in 1974 from Washington University in St. Louis.